|
Thursday, 14 July 2011
The July 2011 issue of International Journal of Radiation Biology highlights a study of the effect of aqueous propolis extract (AEP) against indomethacin (Indo)-induced gastric ulcers in irradiated and non-irradiated rats. more... |
|
|
Friday, 8 July 2011
Caffeic acid phenethyl ester (CAPE), an active component of propolis, has been proven to have anti-inflammatory and antiallergic properties. The authors have investigated the activity of CAPE in regulating cytokine-induced eotaxin production and its related signal protein, signal transducer and activator of transcription 6 (STAT6), in human lung fibroblast. more... |
|
|
Friday, 8 July 2011
Researchers set out with the objective to determine the preventative effect of caffeic acid phenethyl ester (CAPE) in necrotizing enterocolitis (NEC) in an experimental rat model of NEC. Their conclusion: Treatment with CAPE reduces the intestinal damage in NEC. more... |
|
|
Friday, 8 July 2011
In this study, the authors investigated caffeic acid phenethyl ester (CAPE) as a selective GST inhibitor in the presence of tyrosinase, which is abundant in melanoma cells. more... |
|
|
Tuesday, 14 June 2011
Chinese researchers investigated the effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus (T2DM) rats. Their findings showed that oral administration of encapsulated propolis can control blood glucose, modulate lipid metabolism, and improve the insulin sensitivity in T2DM rats. more... |
|
|
Wednesday, 8 June 2011
Breast cancer patients use alternative and natural remedies more than patients with other malignancies. Specifically, 63-83% use at least one type of alternative medicine and 25-63% use herbals and vitamins. This new study reveals that CAPE (caffeic acid phenethyl ester), the major medicinal component of propolis, appears to inhibit tumor growth, both in vitro and in vivo without much effect on normal mammary cells. more... |
|
|
Monday, 6 July 2009
Professor Hiroshi Maruta visited New Zealand from 29th of June till the 5th of July 2009 on invitation from Nutrigenomics NZ in association with Manuka Health NZ more... |
|
Tuesday, 28 October 2008
A bee-derived product manufactured by Manuka Health New Zealand, in Te Awamutu, is helping international researchers in the fight against cancer. more... |
|
Tuesday, 30 September 2008
Bio 30, a CAPE-rich water-miscible extract of propolis from NZ (New Zealand),
has been shown by us (Demestre, M. et al, 2008) to suppress the growth of several tumors in vivo (xenografts in mice): deadly pancreatic cancer, breast cancer, and NF (neurofibromatosis) tumors (both deadly NF1 MPNST and NF2 Schwannoma). more... |
|
